On the recordApril 4, 2017
The 21st Century Cures Act requires FDA to update guidance and regulations for regenerative therapeutic products.
Source
congress.govThe 21st Century Cures Act requires FDA to update guidance and regulations for regenerative therapeutic products.
Burr emphasizes the importance of updating FDA regulations for innovative therapies.
Share & report
More from Richard Burr